A phase II window study of irinotecan (CPT-11) in high risk ewing sarcoma: A Euro-E.W.I.N.G. study
Author:
Affiliation:
1. Department of Oncology; Birmingham Children's Hospital; Birmingham UK
2. Department of Radiology; John Radcliffe Hospital; Oxford UK
3. London Sarcoma Service; University College Hospital; London UK
Funder
Department of Health's NIHR Biomedical Research Centre
Publisher
Wiley
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24767/fullpdf
Reference31 articles.
1. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults;Kushner;J Clin Oncol,1995
2. Results of treatment of primary metastatic Ewing sarcoma. A retrospective analysis of 48 patients [Behandlungsergebnisse beim primär metastasierten Ewing-Sarkom. Eine retrospektive Analyse von 48 Patienten];Wessalowski;Klin Pädiatr,1988
3. Results of treatment of primary exclusively pulmonary metastatic Ewing sarcoma. A retrospective analysis of 41 patients [Behandlungsergebnisse beim primär ausschliesslich pulmonal metastasierten Ewingsarkom. Eine retrospektive Analyse von 41 Patienten];Paulussen;Klin Pädiatr,1993
4. on behalf of EICESS. Primary metastatic (stage IV) Ewing tumor. Survival analysis of 171 patients from the EICESS studies;Paulussen;Ann Oncol,1998
5. Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts;Hare;Cancer Chemother Pharmacol,1997
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents;Pediatric Drugs;2023-04-04
2. Longer versus Shorter Schedules of Vincristine, Irinotecan, and Temozolomide (VIT) for Relapsed or Refractory Ewing Sarcoma: A Randomized Controlled Phase 2 Trial;Clinical Cancer Research;2023-01-09
3. Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study;Cancers;2021-06-18
4. Anlotinib, Vincristine, and Irinotecan for Advanced Ewing Sarcoma After Failure of Standard Multimodal Therapy: A Two-Cohort, Phase Ib/II Trial;The Oncologist;2021-03-08
5. Contemporary Approach to Therapy for Ewing Sarcoma;Sarcomas of Bone and Soft Tissues in Children and Adolescents;2020-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3